Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes |
Aug 2020 |
Nature Medicine |
Myelodysplastic Syndromes (MDS) |
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes |
Oct 2023 |
Oncologist |
Myelodysplastic Syndromes (MDS) |
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
Dec 2023 |
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
Eltrombopag in children with severe aplastic anemia |
Apr 2021 |
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort |
Aug 2020 |
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium |
Aug 2020 |
Pediatric Blood & Cancer |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric |
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. |
Sep 2020 |
PloS One |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction |
Jun 2023 |
SAGE Open Medicine |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Iron Overload Alters the Energy Metabolism in Patients With Myelodysplastic Syndromes: Results From the Multicenter FISM BIOFER Study |
Jun 2020 |
Scientific Reports |
Myelodysplastic Syndromes (MDS) |
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates |
Jan 2019 |
Semin Hematol |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |